Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Evaluation of the Diagnostic Performance of Non-Invasive Prenatal Diagnosis for Single Gene Disorders

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06147414
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:29:03.795190+00:00
Published At
2026-04-23T00:00:00+00:00
Record Updated At
2026-04-23
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, Including", "Sickle Cell Disease", "Cystic Fibrosis", "Fragile X Syndrome", "Proximal Spinal Muscular Atrophy", "Myotonic Dystrophy", "Muscular Dystrophy, Duchenne", "Muscular Dystrophy, Becker", "Neurofibromatosis-Noonan Syndrome", "Huntington Disease", "Hemophilia A", "Hemophilia B", "MODY2 Diabetes", "X-Linked Hydrocephalus", "Autosomal Recessive Polycystic Kidney Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-23"
protocolSection.identificationModule.nctId
"NCT06147414"
protocolSection.identificationModule.officialTitle
"Evaluation of the Diagnostic Performance of Non-Invasive Prenatal Diagnosis for Single Gene Disorders"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, Including (protocolSection.conditionsModule.conditions)
  • Sickle Cell Disease (protocolSection.conditionsModule.conditions)
  • Cystic Fibrosis (protocolSection.conditionsModule.conditions)
  • Fragile X Syndrome (protocolSection.conditionsModule.conditions)
  • Proximal Spinal Muscular Atrophy (protocolSection.conditionsModule.conditions)
  • Myotonic Dystrophy (protocolSection.conditionsModule.conditions)
  • Muscular Dystrophy, Duchenne (protocolSection.conditionsModule.conditions)
  • Muscular Dystrophy, Becker (protocolSection.conditionsModule.conditions)
  • Neurofibromatosis-Noonan Syndrome (protocolSection.conditionsModule.conditions)
  • Huntington Disease (protocolSection.conditionsModule.conditions)
  • Hemophilia A (protocolSection.conditionsModule.conditions)
  • Hemophilia B (protocolSection.conditionsModule.conditions)
  • MODY2 Diabetes (protocolSection.conditionsModule.conditions)
  • X-Linked Hydrocephalus (protocolSection.conditionsModule.conditions)
  • Autosomal Recessive Polycystic Kidney Disease (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.